Document Detail


A comprehensive evaluation of the proficiency testing program for the HIV-1 BED incidence assay.
MedLine Citation:
PMID:  21832016     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
The HIV-1 BED incidence assay was developed at the Centers for Disease Control and Prevention and since 2005 has been available as a commercial kit for use in HIV-1 incidence surveillance. A BED-specific proficiency testing (PT) program was initiated in 2006 that included a panel of eight coded specimens (six unique and two duplicates) to participating laboratories. The number of participating laboratories increased from 12 to 38 from 2006 to 2009. Overall, 96.1% of the laboratories reported results, and 95.4% of those reporting achieved a 100% score. The observed mean normalized optical density (OD-n) values of all participants correlated well with the expected OD-n values for all specimens (R(2) = 0.98) used for seven PT rounds. BED testing demonstrated high reproducibility among all laboratories, with an agreement of 99.3% (574/578) between initial and confirmatory classification and regression statistics of R(2) = 0.96, slope = 1.022, and intercept = 0.0066. Reproducibility among duplicate specimens was very high during each PT round, with mean deviation of 1.8%. Analysis of controls and calibrator specimen for all 343 runs showed a coefficient of variation of ca. 20% for raw ODs in the dynamic range, which was reduced to <10% when the OD was normalized (OD-n). Most laboratories that failed the PT assessment had transcriptional errors, kit reagent problems, or specimen handling errors. Thus, the BED-specific PT program enabled us to track performance of different laboratories conducting the BED assay while identifying areas for improvements. This program will also serve as a template for future PT programs for new incidence assays as they become available.
Authors:
Trudy Dobbs; Xin Liu; Rebecca Anderson; John Nkengasong; Bharat S Parekh
Related Documents :
7712326 - Assessment of basic medical sciences in an integrated systems-based curriculum.
11828586 - Multiskilling: a course to increase multidisciplinary skills in future dietetics profes...
19038156 - A phenomenological evaluation: using storytelling as a primary teaching method.
11753916 - Gross anatomy in the surgical curriculum in switzerland: improved cadaver preservation,...
19146076 - The role of phonology and phonologically related skills in reading instruction for stud...
20715326 - Linking traditional knowledge and environmental practice in ontario.
Publication Detail:
Type:  Evaluation Studies; Journal Article; Multicenter Study; Research Support, U.S. Gov't, P.H.S.     Date:  2011-08-10
Journal Detail:
Title:  Journal of clinical microbiology     Volume:  49     ISSN:  1098-660X     ISO Abbreviation:  J. Clin. Microbiol.     Publication Date:  2011 Oct 
Date Detail:
Created Date:  2011-09-30     Completed Date:  2012-01-23     Revised Date:  2012-04-02    
Medline Journal Info:
Nlm Unique ID:  7505564     Medline TA:  J Clin Microbiol     Country:  United States    
Other Details:
Languages:  eng     Pagination:  3470-3     Citation Subset:  IM    
Affiliation:
International Laboratory Branch, Division of Global HIV/AIDS, Centers for Disease Control and Prevention, 1600 Clifton Rd., Atlanta, GA 30329, USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Clinical Laboratory Techniques / methods*,  standards*
HIV Antibodies / blood
HIV Infections / diagnosis*,  epidemiology*
HIV-1 / genetics,  isolation & purification*
Humans
Immunoenzyme Techniques / methods,  standards
Immunoglobulin G / blood
Incidence
Observer Variation
Quality Control
Reproducibility of Results
Virology / methods*,  standards*
Chemical
Reg. No./Substance:
0/HIV Antibodies; 0/Immunoglobulin G

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Bead-based multiplex genotyping of 58 cutaneous human papillomavirus types.
Next Document:  Extent of antigenic cross-reactivity among highly pathogenic H5N1 influenza viruses.